A detailed history of Smithfield Trust CO transactions in Dexcom Inc stock. As of the latest transaction made, Smithfield Trust CO holds 80 shares of DXCM stock, worth $6,914. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80
Previous 80 -0.0%
Holding current value
$6,914
Previous $10,000 40.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$110.31 - $140.45 $27,025 - $34,410
-245 Reduced 75.38%
80 $10,000
Q4 2023

Feb 07, 2024

BUY
$75.49 - $124.16 $12,455 - $20,486
165 Added 103.13%
325 $40,000
Q2 2022

Aug 11, 2022

BUY
$67.99 - $132.89 $8,158 - $15,946
120 Added 300.0%
160 $12,000
Q4 2020

Feb 12, 2021

SELL
$78.0 - $104.5 $40,560 - $54,340
-520 Reduced 92.86%
40 $15,000
Q2 2020

Aug 14, 2020

BUY
$62.68 - $105.34 $18,804 - $31,602
300 Added 115.38%
560 $227,000
Q1 2020

May 05, 2020

BUY
$47.79 - $75.63 $12,425 - $19,663
260 New
260 $70,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $33.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Smithfield Trust CO Portfolio

Follow Smithfield Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithfield Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Smithfield Trust CO with notifications on news.